Cardiovascular and Venous Thromboembolic Risk With Janus Kinase Inhibitors in Immune‐Mediated Inflammatory Diseases: A Systematic Review and Meta‐Analysis of Randomized Trials by Muhammad Haisum Maqsood, Brittany N. Weber, Rebecca H. Haberman, Kristen I. Lo Sicco, Sripal Bangalore, Michael S. Garshick

Get full text

1206 Evaluation of SARS-CoV-2 IgG antibody reactivity in a multi-racial/ethnic cohort of patients with systemic lupus erythematosus by Amit Saxena, Jill P Buyon, Ruth Fernandez-Ruiz, Peter M Izmirly, Mimi Y Kim, Jose U Scher, H Michael Belmont, Rebecca H Haberman, Rochelle Castillo, Kristina K Deonaraine, Allison Guttmann, Mala Masson, Alexis J Engel, Ashira D Blazer

Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo cont... by Joseph F Merola, Lihi Eder, Proton Rahman, Soumya D Chakravarty, Jose U Scher, Alexis Ogdie, Rebecca B Blank, Vincent Piguet, C T Ritchlin, Jonathan Samuels, Kun Qian, Wayne Gulliver, Ralf G Thiele, Rebecca H Haberman, Rochelle Castillo, Cinty Gong, Andrea L Neimann, Katrina A MacFarlane, Sydney Catron, Michael Toprover, Zakwan Uddin, Jiyuan Hu, Francisco Tausk, Jensen Yeung

Get full text

COVID-19 outcomes in patients with psoriasis and psoriatic arthritis: A prospective cohort study by Di Yan, MD, Avani M. Kolla, BPhil, Trevor Young, MD, Lauren Fried, MD, Shruthi Shankar, BS, Lauren Rangel, MD, Lu Yin, MD, Rochelle Castillo, MD, Alexa Steuer, MD, Katerina Svigos, MD, Peter Izmirly, MD, Vaish Sekar, MD, Robert Lesser, MD, Gary Solomon, MD, Rebecca B. Blank, MD, Rebecca H. Haberman, MD, Andrea L. Neimann, MD, Jose U. Scher, MD

Get full text